Sign up
Log in
12 Health Care Stocks Moving In Friday's Intraday Session
Share
Listen to the news

Gainers

  • Regencell Bioscience (NASDAQ:RGC) stock moved upwards by 43.9% to $305.0 during Friday's regular session. The company's market cap stands at $3.9 billion.
  • Phathom Pharmaceuticals (NASDAQ:PHAT) shares rose 39.29% to $3.19. The company's market cap stands at $222.1 million.
  • SCWorx (NASDAQ:WORX) shares rose 38.75% to $0.76. The market value of their outstanding shares is at $1.7 million.
  • Definitive Healthcare (NASDAQ:DH) shares increased by 32.74% to $3.73. The market value of their outstanding shares is at $402.7 million. The company's, Q1 earnings came out yesterday.
  • Corvus Pharma (NASDAQ:CRVS) shares increased by 29.85% to $4.35. The market value of their outstanding shares is at $296.5 million. The company's, Q1 earnings came out yesterday.
  • LogicMark (NASDAQ:LGMK) shares rose 28.37% to $0.01.

Losers

  • NuCana (NASDAQ:NCNA) stock fell 53.8% to $0.05 during Friday's regular session.
  • Iovance Biotherapeutics (NASDAQ:IOVA) stock declined by 43.85% to $1.78. The company's market cap stands at $594.4 million. As per the press release, Q1 earnings came out yesterday.
  • Organogenesis Holdings (NASDAQ:ORGO) stock decreased by 43.36% to $3.02. The market value of their outstanding shares is at $383.7 million. As per the press release, Q1 earnings came out yesterday.
  • ENDRA Life Sciences (NASDAQ:NDRA) stock decreased by 43.09% to $3.5. The company's market cap stands at $1.8 million.
  • CVRx (NASDAQ:CVRX) shares decreased by 37.46% to $4.87. The company's market cap stands at $126.6 million. The company's, Q1 earnings came out yesterday.
  • Polyrizon (NASDAQ:PLRZ) stock decreased by 35.85% to $0.38. The market value of their outstanding shares is at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.